Phreesia, Inc. (PHR): Results of Operations and Financial Condition
Phreesia, Inc. (PHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del., September 2, 2026 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia deli
How this was made
The 30-second read
Why it matters
The earnings beat and maintained guidance suggest short‑term upside, but restructuring costs and debt levels warrant caution.
Market read
First‑report earnings with positive surprise; relevant for traders targeting healthcare tech stocks.
What to watch
Restructuring charges of $10M and debt reduction may limit near‑term cash flexibility.
Background
Phreesia filed a Form 8‑K reporting its Q2 FY2027 results, including revenue growth, profitability expansion, and updated FY2027 outlook.
Ticker impact
Q2 fiscal 2027 results disclosed with revenue up 10% YoY, net income $1.9M, and updated FY2027 guidance.
Potential modest price appreciation in the next few trading sessions.
First‑report earnings with better-than-expected profit and solid cash flow, plus guidance range maintained.
Market effects
Healthcare services software sector may see renewed interest as Phreesia shows profitability.
U.S. market participants focused on digital health earnings.
Limited to U.S. investors; no broader macro effect.
Counterpoint
Guidance remains flat; execution risk on restructuring savings could pressure the stock.
Key entities
- companyPhreesia, Inc.
Digital health platform reporting Q2 FY2027 results.
- executiveChaim Indig
CEO and Co‑Founder who commented on results.
